ACTIVE_NOT_RECRUITING

Retrospective Study of AlloMend Acellular Dermal Matrix (ADM) Allograft and Pre-Pectoral Breast Reconstruction

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

This retrospective, single-site study will provide information regarding the efficiency of AlloMend® Acellular Dermal Matrix allograft in Pre-Pectoral Breast Reconstruction surgery following a single or double mastectomy.

Official Title

A Study to Evaluate the Safety and Effectiveness of AlloMend® Acellular Dermal Matrix Used in Post Mastectomy Pre-Pectoral Breast Reconstruction and Followed for Up To 12-Months Post-Operatively

Quick Facts

Study Start:2025-01-27
Study Completion:2026-05-31
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:ACTIVE_NOT_RECRUITING

Study ID

NCT06853964

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years
Sexes Eligible for Study:FEMALE
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * Female ≥ 18 years old.
  2. * Patients have undergone a single or double mastectomy, followed by AlloMend® Acellular Dermal Matrix -assisted, pre-pectoral breast reconstruction.
  3. * Patients have undergone either one-stage (direct-to-implant) or two-stage (expander-to-implant), unilateral or bilateral pre-pectoral breast reconstruction using AlloMend®.
  1. * Did not utilize AlloMend® Acellular Dermal Matrix allograft during pre-pectoral breast reconstruction
  2. * Did not have post-operative evaluations at the clinical site.

Contacts and Locations

Study Locations (Sites)

Janiga MDs Plastic Surgery and Cosmetic Center
Reno, Nevada, 89521
United States

Collaborators and Investigators

Sponsor: AlloSource

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2025-01-27
Study Completion Date2026-05-31

Study Record Updates

Study Start Date2025-01-27
Study Completion Date2026-05-31

Terms related to this study

Keywords Provided by Researchers

  • AlloMend
  • Acellular Dermal Matrix
  • Pre-pectoral Breast Reconstruction
  • Allografts

Additional Relevant MeSH Terms

  • Pre-Pectoral Breast Reconstruction Following Mastectomy